Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum

참고문헌 (10)

1. Goto Akihiko, "The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum", Infection and Chemotherapy, 53(3), pp.562~564 (2021), 대한감염학회[DOI]
2. Kang CI, "Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae", J Infect, 64, pp.533~534 (2012)
3. Rodríguez-Baño J, "β-Lactam", β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts, 2012, pp.54, 167~174
4. Tamma PD, "The Use of Noncarbapenem β-lactams for the treatment of extendedspectrum β-lactamase infections", Clin Infect Dis, 64, pp.972~980 (2017)
5. Son SK, "Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis", J Antimicrob Chemother, 73, pp.2631~2642 (2018)
6. Harris PNA, "Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial", JAMA, 320, pp.984~994 (2018)
7. Tamma PD, "Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)", Clin Infect Dis, 72, pp.1109~1116 (2021)
8. Hayden MK, "Carbapenem-sparing therapy for extended-spectrum β-lactamase-producing E coli and Klebsiella pneumoniae bloodstream infection: the search continues", s. JAMA, 320, pp.979~981 (2018)
9. Paterson DL, "New treatment options for multiresistant gram negatives", Curr Opin Infect Dis, 33, pp.214~223 (2020)
10. Aslan AT, "Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options", Expert Rev Anti Infect Ther, 17, pp.969~981 (2019)

관련 논문AI추천